Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-023532
Filing Date
2025-07-25
Accepted
2025-07-25 16:35:02
Documents
1
Period of Report
2025-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3157
  Complete submission text file 0001437749-25-023532.txt   4684
Mailing Address 394 SADDLE BACK TRAIL FRANKLIN LAKES NJ 07417
Business Address
JACINTO RICHARD II (Reporting) CIK: 0001196834 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36291 | Film No.: 251152085

Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Issuer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)